Company Profile For Cadila Healthcare Ltd

Cadila Healthcare Limited is a pharmaceutical company that discovers, develops, manufactures and markets a range of healthcare products. Its operations range from active pharmaceutical ingredient (API) to formulations, animal health products and cosmeceuticals. It has operations in four continents spread across the United States, Europe, Japan, Brazil, South Africa. During the fiscal year ended March 31, 2009, the Company launched over 25 new products and over 30 line extensions in the formulations market. Zydus Pharmaceuticals (USA) Inc., the Company's subsidiary in the United States. It has manufacturing facilities for APIs and formulations, spread across five states, which include Gujarat, Maharashtra, Goa, Himachal Pradesh and Sikkim. In February 2009, Zydus Family Trust acquired 73.91% of interest in the Company. As a result, Zydus Family Trust holds 74.56% interest in the Company.

BRIEF: For the six months ended 30 September 2009, Cadila Healthcare Limited's revenues increased 27% to RS18.58B. Net income increased 39% to RS2.57B. Revenue reflects increased in income from operations. Net income also reflects a decrease in exchange rate fluctuations. Cadila Healthcare Limited is a global pharmaceutical company that discovers, develops, manufactures and markets a range of healthcare products.

Cadila Healthcare Ltd
Zydus Tower
Satellite Cross Roads
Ahmedabad     380 015
P: +9179.26868100
F: +9179.26862366

10037